Gilead Sciences (NQ:GILD)

Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes

Topics Credit Cards

September 29, 2025

Merus N.V. (NASDAQ: MRUS) has become the undisputed top performer in today's market, with its stock price rocketing by an astounding 35.9% following the bombshell announcement of its acquisition by...

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps...

September 29, 2025

Lupin Gains On FDA Nod For HIV Drug; Technicals Suggest Potential Upside Above ₹2,060 ↗

September 25, 2025

SLB, Apple, Nvidia, Merck, Gilead Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

September 11, 2025

Why Is Novo Nordisk’s Stock Rising Premarket Today? ↗

September 10, 2025

U.S. Government Teeters on Brink of Shutdown: Markets Brace for Uncertainty Amidst Data Blackout Fears

September 29, 2025

As the clock ticks towards the September 30, 2025, funding deadline, the United States federal government finds itself perilously close to another shutdown. Congressional leaders remain deadlocked on a...

Gilead Sciences Inc (NASDAQ:GILD) Shows Strong Technical Setup for Potential Breakout ↗

Topics Bonds Economy Government

September 24, 2025

Gilead Sciences (GILD) shows strong technicals with a top rating of 9. It's forming a high-quality consolidation pattern, suggesting a potential breakout above $117.42.

Via Chartmill

If You Invested $100 In Gilead Sciences Stock 20 Years Ago, You Would Have This Much Today ↗

September 23, 2025

Via Benzinga

Xilio Stock Jumps 8% On Cancer Drug Data; Gilead Boost Extends Cash Runway Into 2027 — Retail Says Stock Undervalued ↗

September 09, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

3 Profitable Stocks We’re Skeptical Of

September 23, 2025

Gilead Sciences has been treading water for the past six months, holding steady at $112.78. The stock also fell short of the S&P 500’s 16.5% gain during that period.

What Analysts Are Saying About Gilead Sciences Stock ↗

September 16, 2025

Via Benzinga

3 Reasons GILD is Risky and 1 Stock to Buy Instead

September 16, 2025

U.S. Economy Braces for Significant Slowdown: Leading Indicators Signal Weakening, Not Yet Recession

Topics Government Stocks

September 15, 2025

The U.S. economy finds itself at a critical juncture, as signals from The Conference Board's Leading Economic Index (LEI) point toward a sustained period of economic weakening. While the LEI's...

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.

Topics Artificial Intelligence Economy Supply Chain

These S&P500 stocks are gapping in today's session ↗

September 15, 2025

Via Chartmill

Biotech Sector May Flip to Market Leader by Year-End ↗

September 15, 2025

As rate cuts loom and after years of lagging, the biotech sector is showing signs of life, with IBB outpacing the benchmark S&P 500 on the quarter.

Via MarketBeat

Topics ETFs Economy Stocks

GILEAD SCIENCES INC (NASDAQ:GILD): A Prime Value Investing Candidate with Strong Fundamentals ↗

September 13, 2025

Gilead Sciences (GILD) is a strong value investing candidate, trading at a significant discount with high profitability, solid financial health, and positive growth prospects.

Via Chartmill

Cooling Wages Cast a Shadow: Economic Recovery at Risk as Consumer Spending Slows

September 10, 2025

The American economy is facing a new headwind as weakening wage growth begins to temper consumer spending, raising concerns about the pace and sustainability of the broader economic recovery. Recent...

American households are bracing for a significant financial hit as a wave of tariff-induced inflation sweeps across critical consumer goods and services. From the family car to essential baby products,...

Topics Credit Cards Economy Supply Chain

Tariffs Cast a Long Shadow: Consumer Prices Soar Across Essential Goods

September 10, 2025

Wolfspeed, Nvidia, Gilead, SLBM, Corning: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗

Topics Economy Government World Trade

September 09, 2025

On Monday, the tech-heavy Nasdaq Composite climbed to a new high despite the ongoing uncertainty regarding the state of the U.S. economy and the rate outlook.

The global economy is currently grappling with a projected deceleration in GDP growth, a situation severely exacerbated by an unprecedented escalation of U.S. tariffs. These twin forces are creating a...

Topics Artificial Intelligence Bankruptcy Economy

Global Economic Slowdown and Escalating Tariffs: A Looming Threat to Market Growth

September 08, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Topics Economy Supply Chain World Trade

1 Healthcare Stock to Consider Right Now and 2 We Question

September 03, 2025

September is historically the worst month for stocks, but these 10 S&P 500 companies have consistently delivered gains.

Topics Stocks

Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles ↗

September 02, 2025

Via Benzinga

Topics Stocks

Veeva Makes A Bearish Move On One Pockmark In Its Quarterly Report ↗

August 27, 2025

The company beat second-quarter expectations, with the exception of one key metric.

Eli Lilly said Tuesday it will soon ask global regulators to approve its weight-loss pill following a third successful test.

Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump ↗

August 26, 2025

The drug is soon to launch in Europe with a new name and a big potential market.

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win ↗

August 26, 2025

Options Corner: Why The Market Could Be Prescribing A Bull Call Spread For Gilead Sciences ↗

August 25, 2025

While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an opportunity.

Via Benzinga

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years ↗

August 22, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 22, 2025

Via Benzinga

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. ↗

August 22, 2025

The tariffs will impact products imported from Europe, the Trump administration said late Thursday.